Article
Sunday, April 25, is also Symposia Day at ARVO, and a series of sessionsof broad scientific interest is being offered in the morning and afternoon.
First patient dosed in clinical trial to treat neuropathic corneal pain
Week in Review - October 5, 2024
Real-world evidence on latest retinal disease therapies
Innovation Series: AI’s impact on managing ocular surface disease with Peter J. McDonnell, MD, and Laura M. Periman, MD
New case study seeks to enhance perspectives in international ophthalmology partnerships
Life Biosciences reports advances in nonhuman primate studies on partial epigenetic reprogramming for restoring visual function